CERS Net Margin
-3.06%TTM
Period ending:
CERS FY Net Margin%
293.64%-2186.71%
1997-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
CERS net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 29 observations from Dec 31, 1997 to Dec 31, 2025.
| Period ending | Net Margin |
|---|---|
| -7.581% | |
| -11.6037% | |
| -23.975% | |
| -26.399% | |
| -41.5516% | |
| -65.1186% | |
| -95.4387% | |
| -94.5098% | |
| -139.0585% | |
| -169.1795% | |
| -163.2469% | |
| -105.6516% | |
| -109.2796% | |
| -43.3765% | |
| -51.3921% | |
| -73.1793% | |
| -134.2176% | |
| -176.7795% | |
| -410.2137% | |
| -13.4317% | |
| 53.6047% | |
| -223.9451% | |
| -602.866% | |
| -673.6396% | |
| -1,088.5777% | |
| -1,946.6775% | |
| -941.6667% | |
| -1,020.6897% | |
| -213.0435% |
Compare net margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net margin
- Bridgebio Pharma Inc (BBIO) net margin
- Brightspring Health Services Inc (BTSG) net margin
- Madrigal Pharmaceuticals Inc (MDGL) net margin
- Ensign Group Inc (ENSG) net margin
- Glaukos Corp (GKOS) net margin
- Krystal Biotech Inc (KRYS) net margin
- Twist Bioscience Corp (TWST) net margin
Compare all covered stocks by net margin →
All CERS financial metrics · CERS stock overview · How to interpret financial metrics
